Rapid Diagnosis of Campylobacter Infection by Latex Agglutination Using Monoclonal Antibodies.

使用单克隆抗体通过乳胶凝集快速诊断弯曲杆菌感染。

基本信息

  • 批准号:
    61571118
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1986
  • 资助国家:
    日本
  • 起止时间:
    1986 至 1988
  • 项目状态:
    已结题

项目摘要

Campylobacter jejuni, the most frequent pathogens of acute gastroenteritis, usually requires two days for the isolation and identification. We made monoclonal antibodies(MoAb) against C. iejuni so as to search the frequencies of C. jejuni isolation and to establish the method for rapid diagnosis.1) The frequencies of pathogens isolated from feces were 36% in C. jejuni/ coli, 27% in Klebsiella oxytoca, 14% in enteropathogenic E. coli and 9% in Salmonella spp.2) Campylobacter coli shared 8% in all C. jejuni/coli.3) Eleven anti C. jejuni monoclonal antibodies were obtained by means of heat extracted C. jejuni C_1 strain. The epitopes reactive with these MoAb were polypeptides having 45kDa(6 strains) and 65kDa(5 strains) molecular masses on SDS-PAGE. The classes of MoAb were identified as IgM(2 strains) and IgG(9 strains).4) MoAb(H-194) sensitized latex agglutination(reversed passive latex agglutination, RPLA) was verified to be Campylobacter specific when examined by other pathogens of gastroenteritis.5) The sensitivity of the RPLA was 4x10^4 CFU/ml, as calculated from the plate-RPLA and colony formation unit of C. jejuni C strain.6) All clinically isolated 121 strains of C. jejuni and 11 strains of C. coli showed positive RPLA.7) There was a 96%(249 of 260) total agreement between RPLA and the standard culture method. Among 200 feces showed positive culture, 198 were identified as positive RPLA. Nine feces among 60 negative culture showed positive results.In summary, the RPLA appears to be useful for rapid detection(within 10 min) of Campylobacter. The method is sensitive, specific, simple to perform and requires no costly instrument.
空肠弯曲菌是急性胃肠炎最常见的病原菌,其分离鉴定通常需要2天。我们制备了抗C. iejuni,以搜索C. 1)空肠弯曲菌粪便分离率为36%;空肠/大肠杆菌、产酸克雷伯氏菌、肠致病性大肠埃希氏菌分别为27%、14%。大肠弯曲杆菌在所有C. 3)11株抗C.用热浸法提取空肠C.空肠C_1菌株。SDS-聚丙烯酰胺凝胶电泳结果表明,与这些单抗反应的抗原表位为分子量为45 kDa(6株)和65 kDa(5株)的多肽。4)用H-194致敏的乳胶凝集试验(RPLA)检测其他病原菌,结果表明RPLA对弯曲菌具有特异性。6)临床分离的121株C. jejuni和11株C. 7)RPLA与标准培养法的符合率为96%(249/260)。在200份培养阳性粪便中,198份被鉴定为RPLA阳性。在60份阴性粪便中有9份呈阳性结果。综上所述,RPLA可用于快速检测弯曲杆菌(10 min内)。该方法灵敏度高、特异性强、操作简单、不需要昂贵的仪器。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
丹羽朗,他3名: "Western Blot法によるCampylobacter jejuni感染症の血清診断" 臨床病理. 35. 99 (1987)
Akira Niwa 等人 3:“通过蛋白质印迹法进行空肠弯曲菌感染的血清诊断”《临床病理学》35. 99 (1987)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉田 勝彦 他: 臨床病理. 33. 336 (1985)
Katsuhiko Yoshida 等人:临床病理学。33. 336 (1985)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
中村良子,他6名: "Campylobacter jejuni感染症の迅速診断法(第I報)ーmicro ELISAによる抗原検出法についてー" 臨床病理. 34. 277-281 (1986)
Ryoko Nakamura 等 6 人:“空肠弯曲菌感染的快速诊断方法(报告 I)- 使用微 ELISA 的抗原检测方法”《临床病理学》34. 277-281(1986)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshiko Nakamura, Atsushi Takeda, Atsuro Iwasawa, Yoshio Aoki, Katsuhiko Yoshida, Akira Niwa and Setsuko Tazawa: "Rapid diagnosis of Campylobacter infection by latex agglutination using monoclonal antibodies." Journal of the Association for Rapid and Auto
Yoshiko Nakamura、Atsushi Takeda、Atsuro Iwasawa、Yoshio Aoki、Katsuhiko Yoshida、Akira Niwa 和​​ Settsuko Tazawa:“使用单克隆抗体通过乳胶凝集快速诊断弯曲杆菌感染。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKAMURA Yoshiko其他文献

Neural Prediction of the Target "to BUY" or "NOT to BUY" by the ERP- based Cognitive BMI.
目标的神经预测

NAKAMURA Yoshiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKAMURA Yoshiko', 18)}}的其他基金

The role of B cell-activating factor for hepatocarcinogenesis induced by non-alcoholic steatohepatitis.
B细胞激活因子在非酒精性脂肪性肝炎诱发肝癌中的作用。
  • 批准号:
    20K16991
  • 财政年份:
    2020
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Multifaceted function analyses of fever-developing neurons using genetically modified rats
使用转基因大鼠对发热神经元进行多方面功能分析
  • 批准号:
    23790271
  • 财政年份:
    2011
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Management for Emergent Infection and Re-emergent Infection Using Acidic Electrolyzed Water-Manual of Hospital Infection and Food-born Infection-
使用酸性电解水处理突发感染和再发感染-医院感染和食源性感染手册-
  • 批准号:
    11672306
  • 财政年份:
    1999
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Research Grant
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
STABLE CLONE PRODUCTION FOR ANTI-EBV MONOCLONAL ANTIBODIES
抗 EBV 单克隆抗体的稳定克隆生产
  • 批准号:
    10941239
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Development of cancer-specific monoclonal antibodies to the Eph receptor and analysis of their recognition mechanisms
Eph受体癌症特异性单克隆抗体的研制及其识别机制分析
  • 批准号:
    22KJ0297
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Enabling Subcutaneous Delivery of Therapeutic Monoclonal Antibodies via Hydrogel Microparticles
通过水凝胶微粒皮下输送治疗性单克隆抗体
  • 批准号:
    10761250
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Optimizing the Generation of Monoclonal Antibodies for Prevention and Treatment of HSV Disease
优化用于预防和治疗 HSV 疾病的单克隆抗体的生成
  • 批准号:
    10717320
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Probing in situ higher order structures of monoclonal antibodies at water-air and water-oil interfaces via high-field nuclear magnetic resonance spectroscopy for viral infections
通过高场核磁共振波谱技术在水-空气和水-油界面原位探测单克隆抗体的高阶结构以检测病毒感染
  • 批准号:
    10593377
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ
TO6 - 生成针对人类和小鼠 COLQ 的单克隆细胞系、单克隆抗体和标记单克隆抗体
  • 批准号:
    10953997
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Exploration for determinant of PK for monoclonal antibodies targeting antigen/receptor expressed on tumor cells
探索针对肿瘤细胞上表达的抗原/受体的单克隆抗体的 PK 决定因素
  • 批准号:
    23K06216
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SBIR Phase I: Generation of directly active monoclonal antibodies to CD19 for the treatment of B-cell malignancies
SBIR I 期:产生直接活性的 CD19 单克隆抗体,用于治疗 B 细胞恶性肿瘤
  • 批准号:
    2212682
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了